
Novozene Therapeutics Private Limited
About Novozene Therapeutics Private Limited
Data last updated:
Novozene Therapeutics Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the chemicals sector. It was incorporated on 30 December 2011.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC078320.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ananda Rao Mullapudi and Pusuluri Prudhvi.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 1 – 2 – 30/6 Nizampet Road Near Sangamitra School Kukatpally, Hyderabad, Telangana, India – 500072.
Company details
CIN history
Novozene Therapeutics has one previous CIN (Corporate Identification Number): U24232AP2011PTC078320. The current CIN is U24232TG2011PTC078320, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC078320 | Current |
| U24232AP2011PTC078320 | Previous |
Contact details
Novozene Therapeutics Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address1 – 2 – 30/6 Nizampet Road Near Sangamitra School Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Novozene Therapeutics Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Novozene Therapeutics Private Limited, buy the company report.
Board of directors of Novozene Therapeutics Private Limited
Novozene Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ananda Rao Mullapudi Also directs: Thermal Systems (Hyderabad)Private Limited | Director | 30 Dec 2011 | 14 Years 10 Months | As last reported |
| Pusuluri Prudhvi Also directs: J Bueno Consulting Private Limited | Director | 30 Dec 2011 | 14 Years 10 Months | As last reported |
Legal cases
No court or tribunal cases involving Novozene Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novozene Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Novozene Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novozene Therapeutics Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Ananda Rao Mullapudi was appointed as Director on 30 Dec 2011.
Frequently asked questions
Novozene Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Novozene Therapeutics was a private limited company based in Hyderabad, Telangana, India. The company worked in manufacturing, within the chemicals industry. It was incorporated on 30 December 2011 and is registered under CIN U24232TG2011PTC078320. The company has been struck off by the Registrar of Companies and is no longer operational.
Novozene Therapeutics had 2 directors:
- Ananda Rao Mullapudi - Director
- Pusuluri Prudhvi - Director
The CIN (Corporate Identification Number) of Novozene Therapeutics is U24232TG2011PTC078320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Novozene Therapeutics is at 1 – 2 – 306 Nizampet Road Near Sangamitra School Kukatpally, Hyderabad, Telangana, India – 500072.
Novozene Therapeutics was incorporated on 30 December 2011. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Novozene Therapeutics on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Novozene Therapeutics operated in the chemicals industry, in the manufacturing segment. It worked in this industry before it was struck off.
Ananda Rao Mullapudi was appointed as Director on 30 Dec 2011. Pusuluri Prudhvi was appointed as Director on 30 Dec 2011.
Novozene Therapeutics can be reached at its registered office: 1 – 2 – 306 Nizampet Road Near Sangamitra School Kukatpally, Hyderabad, Telangana, India – 500072.

